Raised platelet thiobarbituric acid-reacting substances in proliferative Eales' disease

Indian Journal of Ophthalmology

Volumn 48, Issue 4, 2000, Pages 307-309

  Srivastava, Prachi ^a   Saxena, Sandeep ^a,c   Khanna, Vinay K ^b   Kumar, Dipak ^a   Nath, Rajiv ^a   Seth, Prahlad K ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c G 19 River Bank Colony   (India)

Author keywords

Eales' disease; Lipid peroxidation; Neovascularisation; Oxidative stress; Retina; Thiobarbituric acid reacting substances

Indexed keywords

BIOLOGICAL MARKER; LIPID PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; HUMAN; LIPID PEROXIDATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETINA DISEASE; RETINA NEOVASCULARIZATION; THROMBOCYTE; VASCULITIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD PLATELETS; DISEASE PROGRESSION; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; RETINAL DISEASES; RETINAL NEOVASCULARIZATION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASCULITIS;

EID: 0034571518     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gieser SC, Murphy RP. In: Ryan SJ, editor. Retina. Vol. 2. Medical Retina. St. Louis: C V Mosby Co. 1994. pp 1503-8.
2. Atmaca L S, Idil A, Gunduz K. Visualization of retinal vasculitis in Eales' disease. Ocular Immunol Inflammol 1993;1:41-48.
3. Saxena S, Kumar D. Visual outcome of branch retinal vein occlusion in Eales' disease. Ann Ophthalmol 1999;31:173-75.
4. Saxena S, Kumar D. Macular involvement in Eales' disease. Ann Ophthalmol. 2000;32:98-100.
5. Kumar D, Saxena R C, Saxena S. Vitreous haemorrhage in Eales' disease. Afro-Asian J Ophthalmol 1995;13:109-12.
6. Casey R, Li WW. Factors controlling ocular angiogenesis Am J Ophthalmol 1997;124:521-29.
7. Schultz AS, Grant MB. Neovascular growth factors. Eye 1991;5:170-80.
8. Stefannsson E. Oxygen and diabetic eye disease. Graefes Arch Clin Exp Ophthalmol 1990;228:120-23.
9. Srivastava S, Joshi CS, Sethi PPS, Agrawal AK, Srivastava SK, Seth PK. Altered platelet function in non-insulin dependent diabetes mellitus (NIDDM). Thrombosis Res 1994;76:451-61.
10. Guigliano D, Paolisso G, Ceriello A. Oxidative stress and diabetic complications. Diabetes Care 1996;19:257-67.
11. Wolff SP. The potential role of oxidative stress in diabetes and its complications: Novel implications for theory and therapy. In: Crabbe MJC, editor. Diabetic Complications: Scientific and Clinical Aspects. London:Churchill Livingston; 1987:167-21.
12. Jennings PE, McLaren M, Scott NA, Saniabadi JF. The relationship of oxidative stress to thrombotic tendency in type I diabetic patients with diabetic retinopathy. Diabetic Med 1992;8:860-65.
13. 2+ content in platelets from a group of type II diabetic patients with macrovascular complications. Diabetes Care 1995;18:60-63.
14. Rema M, Mohan V, Bhaskar A, Shanmugasundaram KR. Does oxidant stress play a role in diabetic retinopathy. Indian J Ophthalmol 1995;43:17-21.
15. Bhooma V, Sulochana KN, Biswas J, Ramakrishnan S. Eales' disease : Accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage. Curr Eye Res 1997;16:91-95.
16. Sulochna KN, Biswas J, Ramakrishnan S. Eales' disease: Increased oxidation and peroxidation products of membrane constituents chiefly lipids and decreased antioxidant enzymes and reduced glutathione in vitreous. Curr Eye Res 1999;18:254-59.
17. Saxena S, Khanna VK, Kumar D, Srivastava P, Seth PK. Enhanced oxiclative stress in Eales' disease. Ann Ophthalmol. (In press).
18. Saxena S, Kumar D, Srivastava P, Khanna VK, Seth PK. Low levels of platelet glutathione in Eales' disease. Med Sci Res 1999;27:625-26.
19. Boehme DH, Kosecki R, Carson S, Stern F, Marks N. Lipoperoxidation in human and rat brain tissue: Developmental and regional studies. Brain Res 1977;136:11-21.
20. Atmaca L S, Idil A, Gunduz K. Visualization of retinal vasculitis in Eales' disease. Ocular Immunol Inflammol 1993;1:41-48.
21. Das T, Biswas J, Kumar A, Nagpal F N, Namperumalsamy P, Patnaik B, et al. Eales' disease. Indian J Ophthalmol 1994;42:3-18.
22. Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-67.
23. Armstrong D, Hartnett M, Browne R, Ueda T, Jenis E, Al Jada A, et al. Lipid-peroxide induced synthesis of cytokine growth factors during neovascularization in the retina. Invest Ophthalmol Vis Sci 1995;36:S455.
24. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. Oxidative retinal products and ocular damages in diabetic patients. Free Rad Biol Med 1998;25:369-72.
25. Jamieson D, Chance B, Cadenas E, Boveris A. The relationship of free radical production in hyperoxia. Annu Rev Physiol 1986;48:703-19.
26. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemia pseudohypoxia and diabetic complications. Diabetes 1993;42:801-13.
27. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autooxidative glycosylation: Glucose autoxidation as the cause of protein damage in experimental glycation model of diabetes mellitus and ageing. Biochem J 1988;258:205-12.
28. Ahmed MU, Thorpe R, Bayness JW. Identification of N-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986;261:4889-94.
29. Saxena S, Rajasingh J, Biswas S, Kumar D, Shinohara T, Singh V K. Cellular immune response to retinal S-antigen and interphotoreceptor retinoid binding protein fragments in Eales' disease. Pathobiology 1999;67:37-44.
30. Wu GS, Zhang J, Rao NA. Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 1997;38:1333-39.
31. Shimizu K, Zhang J, Riono WP, Wu GS, Rao NA. Retinal S-antigen and IRBP induce nitric oxide production in macrophages. Invest Ophthalmol Vis Sci 1998;39:S778.